167 related articles for article (PubMed ID: 8347251)
1. [Leukocyte depletion of blood products and anti-HLA immunization].
Valla A
Rev Fr Transfus Hemobiol; 1993 Jun; 36(3):281-91. PubMed ID: 8347251
[TBL] [Abstract][Full Text] [Related]
2. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
[TBL] [Abstract][Full Text] [Related]
4. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.
Andreu G; Dewailly J; Leberre C; Quarre MC; Bidet ML; Tardivel R; Devers L; Lam Y; Soreau E; Boccaccio C
Blood; 1988 Sep; 72(3):964-9. PubMed ID: 3416079
[TBL] [Abstract][Full Text] [Related]
5. The challenge of platelet alloimmunization: management and prevention.
Kickler TS
Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):8-18. PubMed ID: 2134640
[TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of platelet transfusions.
Murphy MF; Waters AH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
Kuntz BM; Wollenhaupt HJ; Brüster HT
Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
[TBL] [Abstract][Full Text] [Related]
9. HLA alloimmunization of surgical patients by transfusion with bedside leukoreduced blood components.
Ohto H; Nomizu T; Kuroda F; Hoshi T; Rokkaku Y
Fukushima J Med Sci; 2003 Jun; 49(1):45-54. PubMed ID: 14603951
[TBL] [Abstract][Full Text] [Related]
10. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
Snyder EL
Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501
[TBL] [Abstract][Full Text] [Related]
11. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization.
Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ
Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466
[No Abstract] [Full Text] [Related]
12. Clinical aspects of platelet transfusion.
Williamson LM
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):643-6. PubMed ID: 1333290
[TBL] [Abstract][Full Text] [Related]
13. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N
Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
Yuan Q; Chen X; Cheng L; Zhou CH; Fu XM; Li YP; Wang NH; Wang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):412-20. PubMed ID: 21906451
[TBL] [Abstract][Full Text] [Related]
15. The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.
Saris A; Kerkhoffs JL; Norris PJ; van Ham SM; Ten Brinke A; Brand A; van der Meer PF; Zwaginga JJ
Transfusion; 2019 Feb; 59(2):470-481. PubMed ID: 30499599
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.
Murphy MF; Brozovic B; Murphy W; Ouwehand W; Waters AH
Transfus Med; 1992 Dec; 2(4):311-8. PubMed ID: 1339584
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte reduction in blood component therapy.
Lane TA; Anderson KC; Goodnough LT; Kurtz S; Moroff G; Pisciotto PT; Sayers M; Silberstein LE
Ann Intern Med; 1992 Jul; 117(2):151-62. PubMed ID: 1605430
[TBL] [Abstract][Full Text] [Related]
18. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
[TBL] [Abstract][Full Text] [Related]
19. [Refractory effect and alloimmunization after transfusion of thrombocytes].
Volkova RI; Agranenko VA
Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions.
Vamvakas EC
Transfus Med Rev; 1998 Oct; 12(4):258-70. PubMed ID: 9798269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
